Boston Scientific Inc. (BSX): Today's Featured Health Services Laggard

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Boston Scientific ( BSX) pushed the Health Services industry lower today making it today's featured Health Services laggard. The industry as a whole closed the day up 0.1%. By the end of trading, Boston Scientific fell $0.16 (-1.3%) to $11.89 on light volume. Throughout the day, 7,580,086 shares of Boston Scientific exchanged hands as compared to its average daily volume of 14,245,000 shares. The stock ranged in price between $11.88-$12.12 after having opened the day at $12.09 as compared to the previous trading day's close of $12.05. Other companies within the Health Services industry that declined today were: OraSure Technologies ( OSUR), down 16.6%, ERBA Diagnostics ( ERB), down 16.4%, Digirad Corporation ( DRAD), down 15.1% and SunLink Health Systems ( SSY), down 10.0%.

Boston Scientific Corporation develops, manufactures, and markets medical devices used in various interventional medical specialties worldwide. Boston Scientific has a market cap of $15.9 billion and is part of the health care sector. Shares are up 108.2% year to date as of the close of trading on Friday. Currently there are 4 analysts that rate Boston Scientific a buy, no analysts rate it a sell, and 16 rate it a hold.

TheStreet Ratings rates Boston Scientific as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, solid stock price performance, compelling growth in net income, expanding profit margins and largely solid financial position with reasonable debt levels by most measures. We feel these strengths outweigh the fact that the company shows weak operating cash flow.

On the positive front, ImmunoCellular Therapeutics ( IMUC), up 35.7%, Biolase ( BIOL), up 9.9%, DaVita HealthCare Partners ( DVA), up 8.9% and Heska Corporation ( HSKA), up 7.9% , were all gainers within the health services industry with Universal Health Services ( UHS) being today's featured health services industry leader.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health services industry could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health services industry could consider ProShares Ultra Short Health Care ( RXD).

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

null

More from Markets

Inside Carnival's Mind Blowing New Horizon Cruise Ship (Video)

Inside Carnival's Mind Blowing New Horizon Cruise Ship (Video)

Jim Cramer: The 10-Year Yield Could Go to 2.75%

Jim Cramer: The 10-Year Yield Could Go to 2.75%

Oil Slumps, Gas Spikes Ahead of Holiday Weekend; Assessing the Chipmakers--ICYMI

Oil Slumps, Gas Spikes Ahead of Holiday Weekend; Assessing the Chipmakers--ICYMI

Week Ahead: Wall Street Looks to Jobs Report as North Korea Meeting Less Certain

Week Ahead: Wall Street Looks to Jobs Report as North Korea Meeting Less Certain

Dow and S&P 500 Decline, Energy Shares Fall as U.S. Crude Oil Slides 4%

Dow and S&P 500 Decline, Energy Shares Fall as U.S. Crude Oil Slides 4%